Mayo Clinic, Site #044

Rochester, Minnesota 55905

0 studies enrolling now · 2 studies all time

What they study most

Chronic Myeloid Leukemia, Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Studies at this site

• Expanded Access Program of Ponatinib — APPROVED_FOR_MARKETING
• Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC) — Stopped early